All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Hepatitis B Virus Infection-34982798

ID	PMID	Mutation	Gene/Protein/Region	Disease	Description	Detail
1	34982798	1610_1614del	EnhII	Hepatitis B Virus Infection	G R C L	View
2	34982798	1630_1635del	EnhII	Hepatitis B Virus Infection	G R C L	View
3	34982798	1653_1655del	EnhII	Hepatitis B Virus Infection	G R C L	View
4	34982798	1717_1721del	EnhII	Hepatitis B Virus Infection	G R C L	View
5	34982798	1718_1721del	EnhII	Hepatitis B Virus Infection	G R C L	View
6	34982798	1726_del	EnhII	Hepatitis B Virus Infection	G R C L	View
7	34982798	1731_del	EnhII	Hepatitis B Virus Infection	G R C L	View
8	34982798	94delH	EnhII	Hepatitis B Virus Infection	G R C L	View
9	34982798	A102G	EnhII	Hepatitis B Virus Infection	G R C L	View
10	34982798	A102I	EnhII	Hepatitis B Virus Infection	G R C L	View
11	34982798	A102R	EnhII	Hepatitis B Virus Infection	G R C L	View
12	34982798	A102V	EnhII	Hepatitis B Virus Infection	G R C L	View
13	34982798	A110K	EnhII	Hepatitis B Virus Infection	G R C L	View
14	34982798	A110S	EnhII	Hepatitis B Virus Infection	G R C L	View
15	34982798	D107R	EnhII	Hepatitis B Virus Infection	G R C L	View
16	34982798	D114G	EnhII	Hepatitis B Virus Infection	G R I C L	View
17	34982798	D119N	EnhII	Hepatitis B Virus Infection	G R I C L	View
18	34982798	E109A	EnhII	Hepatitis B Virus Infection	G R C L	View
19	34982798	E109Y	EnhII	Hepatitis B Virus Infection	G R C L	View
20	34982798	F112L	EnhII	Hepatitis B Virus Infection	G R I C L	View
21	34982798	F117S	EnhII	Hepatitis B Virus Infection	G R I C L	View
22	34982798	K113E	EnhII	Hepatitis B Virus Infection	G R I C L	View
23	34982798	K118E	EnhII	Hepatitis B Virus Infection	G R I C L	View
24	34982798	K118I	EnhII	Hepatitis B Virus Infection	G R I C L	View
25	34982798	K91R	EnhII	Hepatitis B Virus Infection	G R C L	View
26	34982798	K91W	EnhII	Hepatitis B Virus Infection	G R C L	View
27	34982798	K95S	EnhII	Hepatitis B Virus Infection	G R C L	View
28	34982798	L100G	EnhII	Hepatitis B Virus Infection	G R C L	View
29	34982798	L108P	EnhII	Hepatitis B Virus Infection	G R C L	View
30	34982798	L93P	EnhII	Hepatitis B Virus Infection	G R C L	View
31	34982798	M103A	EnhII	Hepatitis B Virus Infection	G R C L	View
32	34982798	M103L	EnhII	Hepatitis B Virus Infection	G R C L	View
33	34982798	P90F	EnhII	Hepatitis B Virus Infection	G R C L	View
34	34982798	R96C	EnhII	Hepatitis B Virus Infection	G R C L	View
35	34982798	S101F	EnhII	Hepatitis B Virus Infection	G R C L	View
36	34982798	S104I	EnhII	Hepatitis B Virus Infection	G R C L	View
37	34982798	S104W	EnhII	Hepatitis B Virus Infection	G R C L	View
38	34982798	T106I	EnhII	Hepatitis B Virus Infection	G R C L	View
39	34982798	T106N	EnhII	Hepatitis B Virus Infection	G R C L	View
40	34982798	T97A	EnhII	Hepatitis B Virus Infection	G R C L	View
41	34982798	V92A	EnhII	Hepatitis B Virus Infection	G R C L	View
42	34982798	V92P	EnhII	Hepatitis B Virus Infection	G R C L	View
43	34982798	Y111D	EnhII	Hepatitis B Virus Infection	G R C L	View
44	34982798	Y111E	EnhII	Hepatitis B Virus Infection	G R C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.